K.Venkatesh Guru , Vignesh Janarthanan , M. Jaganathan , V. Senthil kumar
{"title":"基于遗传U-Net和HBoost的乳腺癌分割和分类多模态集成框架","authors":"K.Venkatesh Guru , Vignesh Janarthanan , M. Jaganathan , V. Senthil kumar","doi":"10.1016/j.bspc.2025.108827","DOIUrl":null,"url":null,"abstract":"<div><div>Breast cancer remains a leading cause of mortality among women worldwide, and early, accurate diagnosis is essential to improving treatment outcomes. Traditional segmentation and classification models often fail in ultrasound imaging due to noisy inputs, imbalanced class distributions, and computational inefficiencies. To address these challenges, we propose M2G-HBoost, a multi-modal ensemble framework explicitly designed for robustness in noisy and unbalanced data conditions. The framework integrates cosine similarity–based Graph Convolutional Network (GCN) augmentation to enrich feature diversity by modeling global topological and attribute relationships, M2GCNet for joint spatial and channel-wise dependency modeling, Genetic U-Net optimized via evolutionary algorithms for parameter-efficient high-accuracy segmentation, and HBoost, a heterogeneous boosting ensemble, for resilient classification. This modular design was chosen to employ complementary strengths: GCN augmentation for data diversity, M2GCNet for rich feature extraction, Genetic U-Net for segmentation precision with low complexity, and HBoost for classification stability under imbalance. On the BUSI dataset, M2G-HBoost achieved a Dice score of 93.58 % and IoU of 91.81 %, outperforming CBAM-RIUnet (76.25 % Dice, 80.73 % IoU), PCA-UNet (80.47 %, 84.12 %), EDCNN (85.99 %, 86.24 %), ELRL-E (87.14 %, 88.67 %), and SegEIR-Net (91.07 %, 89.49 %). In classification, the model reached 96.45 % (benign), 98.53 % (malignant), and 98.87 % (normal), exceeding AdaBoost, XGBoost, and Gradient Boosting. These results demonstrate the superiority and clinical applicability of the proposed method, offering a robust, accurate, and efficient solution for breast cancer segmentation and classification in ultrasound imaging.</div></div>","PeriodicalId":55362,"journal":{"name":"Biomedical Signal Processing and Control","volume":"112 ","pages":"Article 108827"},"PeriodicalIF":4.9000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A multi-modal ensemble framework for breast cancer segmentation and classification using genetic U-Net and HBoost\",\"authors\":\"K.Venkatesh Guru , Vignesh Janarthanan , M. Jaganathan , V. Senthil kumar\",\"doi\":\"10.1016/j.bspc.2025.108827\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Breast cancer remains a leading cause of mortality among women worldwide, and early, accurate diagnosis is essential to improving treatment outcomes. Traditional segmentation and classification models often fail in ultrasound imaging due to noisy inputs, imbalanced class distributions, and computational inefficiencies. To address these challenges, we propose M2G-HBoost, a multi-modal ensemble framework explicitly designed for robustness in noisy and unbalanced data conditions. The framework integrates cosine similarity–based Graph Convolutional Network (GCN) augmentation to enrich feature diversity by modeling global topological and attribute relationships, M2GCNet for joint spatial and channel-wise dependency modeling, Genetic U-Net optimized via evolutionary algorithms for parameter-efficient high-accuracy segmentation, and HBoost, a heterogeneous boosting ensemble, for resilient classification. This modular design was chosen to employ complementary strengths: GCN augmentation for data diversity, M2GCNet for rich feature extraction, Genetic U-Net for segmentation precision with low complexity, and HBoost for classification stability under imbalance. On the BUSI dataset, M2G-HBoost achieved a Dice score of 93.58 % and IoU of 91.81 %, outperforming CBAM-RIUnet (76.25 % Dice, 80.73 % IoU), PCA-UNet (80.47 %, 84.12 %), EDCNN (85.99 %, 86.24 %), ELRL-E (87.14 %, 88.67 %), and SegEIR-Net (91.07 %, 89.49 %). In classification, the model reached 96.45 % (benign), 98.53 % (malignant), and 98.87 % (normal), exceeding AdaBoost, XGBoost, and Gradient Boosting. These results demonstrate the superiority and clinical applicability of the proposed method, offering a robust, accurate, and efficient solution for breast cancer segmentation and classification in ultrasound imaging.</div></div>\",\"PeriodicalId\":55362,\"journal\":{\"name\":\"Biomedical Signal Processing and Control\",\"volume\":\"112 \",\"pages\":\"Article 108827\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical Signal Processing and Control\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1746809425013382\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Signal Processing and Control","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1746809425013382","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
A multi-modal ensemble framework for breast cancer segmentation and classification using genetic U-Net and HBoost
Breast cancer remains a leading cause of mortality among women worldwide, and early, accurate diagnosis is essential to improving treatment outcomes. Traditional segmentation and classification models often fail in ultrasound imaging due to noisy inputs, imbalanced class distributions, and computational inefficiencies. To address these challenges, we propose M2G-HBoost, a multi-modal ensemble framework explicitly designed for robustness in noisy and unbalanced data conditions. The framework integrates cosine similarity–based Graph Convolutional Network (GCN) augmentation to enrich feature diversity by modeling global topological and attribute relationships, M2GCNet for joint spatial and channel-wise dependency modeling, Genetic U-Net optimized via evolutionary algorithms for parameter-efficient high-accuracy segmentation, and HBoost, a heterogeneous boosting ensemble, for resilient classification. This modular design was chosen to employ complementary strengths: GCN augmentation for data diversity, M2GCNet for rich feature extraction, Genetic U-Net for segmentation precision with low complexity, and HBoost for classification stability under imbalance. On the BUSI dataset, M2G-HBoost achieved a Dice score of 93.58 % and IoU of 91.81 %, outperforming CBAM-RIUnet (76.25 % Dice, 80.73 % IoU), PCA-UNet (80.47 %, 84.12 %), EDCNN (85.99 %, 86.24 %), ELRL-E (87.14 %, 88.67 %), and SegEIR-Net (91.07 %, 89.49 %). In classification, the model reached 96.45 % (benign), 98.53 % (malignant), and 98.87 % (normal), exceeding AdaBoost, XGBoost, and Gradient Boosting. These results demonstrate the superiority and clinical applicability of the proposed method, offering a robust, accurate, and efficient solution for breast cancer segmentation and classification in ultrasound imaging.
期刊介绍:
Biomedical Signal Processing and Control aims to provide a cross-disciplinary international forum for the interchange of information on research in the measurement and analysis of signals and images in clinical medicine and the biological sciences. Emphasis is placed on contributions dealing with the practical, applications-led research on the use of methods and devices in clinical diagnosis, patient monitoring and management.
Biomedical Signal Processing and Control reflects the main areas in which these methods are being used and developed at the interface of both engineering and clinical science. The scope of the journal is defined to include relevant review papers, technical notes, short communications and letters. Tutorial papers and special issues will also be published.